Literature DB >> 15741273

Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3.

Mario Barro1, John T Patton.   

Abstract

IFN regulatory factor 3 (IRF3), a constitutively expressed protein localizing largely to the cytoplasm, is a primary effector of the innate immune response. Infection can trigger the phosphorylation, dimerization, and nuclear translocation of IRF3, where the factor stimulates the expression and release of IFN. In this study, we determined that the rotavirus gene 5 product, nonstructural protein 1 (NSP1), interacts with IRF3 in the infected cell. To understand the importance of the interaction, we compared IRF3 activation by rotaviruses expressing wild-type and C-truncated forms of NSP1. The analysis showed that IRF3 underwent dimerization and nuclear translocation and stimulated IFN promoter activity in infected cells expressing truncated NSP1. In contrast, infected cells expressing wild-type NSP1 were characterized by the rapid degradation of IRF3 during the replication cycle, severe decreases in IRF3 dimerization and nuclear translocation, and lack of IFN promoter activity. The implication of these results, that wild-type NSP1 is an antagonist of the IFN-signaling pathway, was confirmed in transient expression assays, which showed that wild-type NSP1, but not the C-truncated protein, induced the degradation of IRF3 fusion proteins. Related experiments indicated that NSP1 mediates IRF3 degradation through a proteasome-dependent pathway. The critical role of NSP1 in promoting cell-to-cell spread of rotavirus was demonstrated by using gene 5-specific short interfering RNAs in plaque assays. Although several viruses have been described that subvert the innate immune response by preventing IRF3 activation, rotavirus is identified as one that accomplishes this task by inducing the degradation of IRF3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741273      PMCID: PMC554789          DOI: 10.1073/pnas.0408376102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways.

Authors:  T Iwamura; M Yoneyama; K Yamaguchi; W Suhara; W Mori; K Shiota; Y Okabe; H Namiki; T Fujita
Journal:  Genes Cells       Date:  2001-04       Impact factor: 1.891

Review 3.  A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: development, utilization and withdrawal.

Authors:  A Z Kapikian
Journal:  Novartis Found Symp       Date:  2001

4.  Effect of intragenic rearrangement and changes in the 3' consensus sequence on NSP1 expression and rotavirus replication.

Authors:  J T Patton; Z Taraporewala; D Chen; V Chizhikov; M Jones; A Elhelu; M Collins; K Kearney; M Wagner; Y Hoshino; V Gouvea
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines.

Authors:  D M Bass
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

6.  Nondefective rotavirus mutants with an NSP1 gene which has a deletion of 500 nucleotides, including a cysteine-rich zinc finger motif-encoding region (nucleotides 156 to 248), or which has a nonsense codon at nucleotides 153-155.

Authors:  K Taniguchi; K Kojima; S Urasawa
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3).

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Sato; K Ozato; T Fujita
Journal:  J Biochem       Date:  1996-07       Impact factor: 3.387

8.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

Authors:  J Talon; M Salvatore; R E O'Neill; Y Nakaya; H Zheng; T Muster; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 9.  Triggering the interferon response: the role of IRF-3 transcription factor.

Authors:  J Hiscott; P Pitha; P Genin; H Nguyen; C Heylbroeck; Y Mamane; M Algarte; R Lin
Journal:  J Interferon Cytokine Res       Date:  1999-01       Impact factor: 2.607

10.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

Authors:  L V Ronco; A Y Karpova; M Vidal; P M Howley
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

View more
  125 in total

1.  Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3.

Authors:  Huifang Zhu; Chunfu Zheng; Junji Xing; Shuai Wang; Shuping Li; Rongtuan Lin; Karen L Mossman
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.

Authors:  Brian P Doehle; Kristina Chang; Arjun Rustagi; John McNevin; M Juliana McElrath; Michael Gale
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Authors:  Tao Peng; Swathi Kotla; Roger E Bumgarner; Kurt E Gustin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction.

Authors:  Gregory T Melroe; Lindsey Silva; Priscilla A Schaffer; David M Knipe
Journal:  Virology       Date:  2006-11-28       Impact factor: 3.616

5.  The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity.

Authors:  Kazima Saira; You Zhou; Clinton Jones
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

6.  Genome heterogeneity of SA11 rotavirus due to reassortment with "O" agent.

Authors:  Catie Small; Mario Barro; Thomas L Brown; John T Patton
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

Review 7.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

8.  Rotavirus infection activates dendritic cells from Peyer's patches in adult mice.

Authors:  Delia V Lopez-Guerrero; Selene Meza-Perez; Oscar Ramirez-Pliego; Maria A Santana-Calderon; Pavel Espino-Solis; Lourdes Gutierrez-Xicotencatl; Leopoldo Flores-Romo; Fernando R Esquivel-Guadarrama
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.

Authors:  Volker Fensterl; Dajana Grotheer; Iris Berk; Stefanie Schlemminger; Angelika Vallbracht; Andreas Dotzauer
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.

Authors:  Theresa Kathrina Resch; Yuhuan Wang; Sungsil Moon; Baoming Jiang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.